{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:45:14Z","timestamp":1775609114637,"version":"3.50.1"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"1","funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ZIA MH002927"],"award-info":[{"award-number":["ZIA MH002927"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NCT00369915"],"award-info":[{"award-number":["NCT00369915"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1093\/ijnp\/pyy051","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T15:30:14Z","timestamp":1532619014000},"page":"10-18","source":"Crossref","is-referenced-by-count":33,"title":["Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder"],"prefix":"10.1093","volume":"22","author":[{"given":"Lawrence","family":"Park","sequence":"first","affiliation":[{"name":"Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Furey","sequence":"additional","affiliation":[{"name":"Janssen Research and Development, LLC, La Jolla, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison C","family":"Nugent","sequence":"additional","affiliation":[{"name":"Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristan","family":"Farmer","sequence":"additional","affiliation":[{"name":"Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Ellis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Szczepanik","sequence":"additional","affiliation":[{"name":"Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc S","family":"Lener","sequence":"additional","affiliation":[{"name":"Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Carlos A","family":"Zarate","sequence":"additional","affiliation":[{"name":"Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,9,1]]},"reference":[{"key":"key\n\t\t\t\t2019010203583546600_CIT0001","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1017\/S1461145714000959","article-title":"Chronic administration of antipsychotics attenuates ongoing and ketamine-induced increases in cortical gamma oscillations","volume":"17","author":"Anderson","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0002","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0031-9384(82)90080-4","article-title":"Further characterization of the behavioral despair test in mice: positive effects of convulsants","volume":"28","author":"Betin","year":"1982","journal-title":"Physiol Behav"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0003","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/mp.2010.24","article-title":"Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder","volume":"16","author":"Cannon","year":"2011","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0004","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/mp.2011.31","article-title":"A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior","volume":"17","author":"Carlen","year":"2012","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0005","first-page":"S1359-6446(1317)30341-30340","article-title":"The role of fMRI in drug development","volume":"15","author":"Carmichael","year":"2017","journal-title":"Drug Discov Today Nov"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0006","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.1074\/jbc.M116.720029","article-title":"Brain-derived neurotrophic factor in megakaryocytes","volume":"291","author":"Chacon-Fernandez","year":"2016","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0007","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neuroimage.2013.01.047","article-title":"Linear mixed-effects modeling approach to FMRI group analysis","volume":"73","author":"Chen","year":"2013","journal-title":"NeuroImage"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0008","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ajmg.10406","article-title":"Association of the muscarinic cholinergic 2 receptor (CHRM2) gene with major depression in women","volume":"114","author":"Comings","year":"2002","journal-title":"Am J Med Genet"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0009","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/cbmr.1996.0014","article-title":"AFNI: software for analysis and visualization of functional magnetic resonance neuroimages","volume":"29","author":"Cox","year":"1996","journal-title":"Comput Biomed Res"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0010","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0006-3223(86)90246-5","article-title":"Pathophysiology of \u201ccholinoceptor supersensitivity\u201d in affective disorders","volume":"21","author":"Dilsaver","year":"1986","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2009.11.021","article-title":"Replication of scopolamine\u2019s antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial","author":"Drevets","year":"2010","journal-title":"Biol Psychiatry 67:432\u2013438"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0012","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.biopsych.2012.09.031","article-title":"Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review","volume":"73","author":"Drevets","year":"2013","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0013","volume-title":"Structured clinical interview for DSM-IV-TR axis I disorders research version, patient edition","author":"First","year":"2001"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0014","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archpsyc.63.10.1121","article-title":"Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial","volume":"63","author":"Furey","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biopsych.2017.06.017","article-title":"Activity-dependent brain-derived neurotrophic factor release is required for the rapid antidepressant actions of scopolamine","volume":"83","author":"Ghosal","year":"2018","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0016","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-3223(91)90170-Q","article-title":"The effects of scopolamine on sleep and mood in depressed patients with a history of alcoholism and a normal comparison group","volume":"30","author":"Gillin","year":"1991","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0017","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fnins.2013.00267","article-title":"MEG and EEG data analysis with MNE-Python","volume":"7","author":"Gramfort","year":"2013","journal-title":"Front Neurosci"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0018","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1017\/S1461145713001119","article-title":"Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression","volume":"17","author":"Haile","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0019","doi-asserted-by":"crossref","DOI":"10.1177\/2470547017697317","article-title":"Rapid acting antidepressants in chronic stress models: molecular and cellular mechanisms","author":"Hare","year":"2017","journal-title":"Chronic Stress (Thousand Oaks)"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0020","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0021","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00006842-197405000-00008","article-title":"Acetylcholine and depression","volume":"36","author":"Janowsky","year":"1974","journal-title":"Psychosom Med"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0022","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(72)93021-8","article-title":"A cholinergic-adrenergic hypothesis of mania and depression","volume":"2","author":"Janowsky","year":"1972","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0023","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1176\/ajp.142.6.738","article-title":"Effects of physostigmine on pulse, blood pressure, and serum epinephrine levels","volume":"142","author":"Janowsky","year":"1985","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0024","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1017\/S1461145714000492","article-title":"Effects of aberrant gamma frequency oscillations on prepulse inhibition","volume":"17","author":"Jones","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mpr.1359","article-title":"Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States","volume":"21","author":"Kessler","year":"2012","journal-title":"Int J Methods Psychiatr Res"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0026","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0033291716000064","article-title":"Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories","volume":"46","author":"Kishimoto","year":"2016","journal-title":"Psychol Med"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0027","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0028","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.4088\/JCP.08m04659","article-title":"Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist","volume":"70","author":"Machado-Vieira","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0029","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/da.22224","article-title":"Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants","volume":"31","author":"Niciu","year":"2014","journal-title":"Depress Anxiety"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0030","article-title":"Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects","author":"Nugent","year":"2018","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0031","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0165-1781(83)90043-4","article-title":"Behavioral, physiological, and neuroendocrine responses to arecoline in normal twins and \u201cwell state\u201d bipolar patients","volume":"9","author":"Nurnberger","year":"1983","journal-title":"Psychiatry Res"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0032","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1001\/jamainternmed.2016.5057","article-title":"Treatment of adult depression in the United States","volume":"176","author":"Olfson","year":"2016","journal-title":"JAMA Intern Med"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0033","first-page":"197","article-title":"Selective breeding for increased cholinergic function: biometrical genetic analysis of muscarinic responses","volume":"7","author":"Overstreet","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0034","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.biopsych.2007.10.006","article-title":"N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex","volume":"63","author":"Pinault","year":"2008","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0035","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004714-198107000-00003","article-title":"Cholinergic challenges in affective illness: behavioral and neuroendocrine correlates","volume":"1","author":"Risch","year":"1981","journal-title":"J Clin Psychopharmacol"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0036","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/schbul\/sbv051","article-title":"Ketamine dysregulates the amplitude and connectivity of high-frequency oscillations in cortical-subcortical networks in humans: evidence from resting-state magnetoencephalography recordings","volume":"41","author":"Rivolta","year":"2015","journal-title":"Schizophr Bull"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0037","article-title":"Functional neuroimaging by synthetic aperture magnetometry (SAM). In: Recent advances in biomagnetism (Yoshimoto T, Kotani M, Kuriki S, Karibe H, Nakasato N, eds), pp302-305. Sendai: Tohoku University Press","author":"Robinson","year":"1999"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(99)00085-2","article-title":"Hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration: sex differences between major depressives and matched control subjects","volume":"89","author":"Rubin","year":"1999","journal-title":"Psychiatry Res"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0039","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.euroneuro.2015.04.012","article-title":"Ketamine amplifies induced gamma frequency oscillations in the human cerebral cortex","volume":"25","author":"Shaw","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0040","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","article-title":"Medication augmentation after the failure of SSRIs for depression","volume":"354","author":"Trivedi","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0041","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am J Psychiatry"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0042","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.biopsych.2013.04.025","article-title":"Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses","volume":"74","author":"Voleti","year":"2013","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0043","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/hmg\/ddh194","article-title":"Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome","volume":"13","author":"Wang","year":"2004","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0044","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1570159X14666160309114549","article-title":"Molecular and cellular mechanisms of rapid-acting antidepressants ketamine and scopolamine","volume":"15","author":"Wohleb","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0045","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.biopsych.2012.11.031","article-title":"Human biomarkers of rapid antidepressant effects","volume":"73","author":"Zarate","year":"2013","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0046","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"key\n\t\t\t\t2019010203583546600_CIT0047","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jpsychires.2004.03.007","article-title":"Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression","volume":"38","author":"Zimmerman","year":"2004","journal-title":"J Psychiatr Res"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/22\/1\/10\/27347495\/pyy051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T05:57:46Z","timestamp":1571637466000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/22\/1\/10\/5089436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,9,1]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyy051","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2018,9,1]]}}}